$205 Mln
--
$-11 Mln
As on 25-Apr-2024 16:10 EDT
$-0.03
•
-1.26%
$2.38
$2.39
$2.40
$2.26
481,919
$1.33 - 3.29
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
| 34.29 | -6.37 | 11.90 | 33.52 | -32.79 | 3.28 | -4.92 |
|
S&P BSE Sensex*
| 2.06 | 1.23 | 4.28 | 22.62 | 15.48 | 13.74 | 12.51 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Stereotaxis (STXS)
| -15.46 | -66.61 | 21.81 | -3.78 | 389.36 | 34.90 | 23.10 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 | 11.73 |
|
S&P BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Stereotaxis Inc. (STXS) stood at $ 42 Mln as on 31-Dec-23
The share price of Stereotaxis Inc. (STXS) is $2.35 (NYSE) as of 25-Apr-2024 16:10 EDT. Stereotaxis Inc. (STXS) has given a return of -32.79% in the last 3 years.
Stereotaxis Inc. (STXS) has a market capitalisation of $ 205 Mln as on 19-Apr-2024. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Stereotaxis Inc. (STXS) is 13.62 times as on 19-Apr-2024, a 2.17% premium to its peers’ median range of 4.30 times.
Since, TTM earnings of Stereotaxis Inc. (STXS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Stereotaxis Inc. (STXS) and enter the required number of quantities and click on buy to purchase the shares of Stereotaxis Inc. (STXS).
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
The CEO & director of Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.. is Stereotaxis Inc. (STXS), and CFO & Sr. VP is Ms. Kimberly R. Peery.
There is no promoter pledging in Stereotaxis Inc. (STXS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
917
|
|
|
915
|
|
|
876
|
|
|
787
|
| Stereotaxis Inc. (STXS) | Ratios |
|---|---|
|
Return on equity(%)
|
-85.82
|
|
Return on capital employed(%)
|
-69.48
|
|
Debt-to-equity ratio
|
0.34
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Stereotaxis Inc. (STXS) was $-11 Mln.
$204.50 Mln
$26.77 Mln
$-10.97 Mln
$20.34 Mln
$5.49 Mln
Moderate
$1.33 - 3.29
82,128,800
NYSE: STXS
Saint Louis, MO
https://www.stereotaxis.com
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis... RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri. Read more
Widely used:
